CoMentis

Quick facts

Phase 2 pipeline

• DMXB-A · Neurology
  DMXB-A is a potent agonist of the CB1 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CoMentis portfolio CI brief
• CoMentis pipeline updates RSS